|
🐜
|
Revised international prognostic scoring system for myelodysplastic syndromes.
34 auth.
P. Greenberg,
H. Tuechler,
J. Schanz,
G. Sanz,
G. Garcia-Manero,
F. Solé,
J. Bennett,
D. Bowen,
P. Fenaux,
F. Dreyfus,
H. Kantarjian,
A. Kuendgen,
A. Levis,
L. Malcovati,
M. Cazzola,
...
J. Čermák,
C. Fonatsch,
M. L. Le Beau,
M. Slovak,
O. Krieger,
M. Luebbert,
J. Maciejewski,
S. Magalhães,
Y. Miyazaki,
M. Pfeilstöcker,
M. Sekeres,
W. Sperr,
R. Stauder,
S. Tauro,
P. Valent,
T. Vallespí,
A. A. van de Loosdrecht,
U. Germing,
D. Haase
|
11 |
2012 |
11
🐜
|
|
🐜
|
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.
19 auth.
D. Haase,
U. Germing,
J. Schanz,
M. Pfeilstöcker,
T. Nösslinger,
B. Hildebrandt,
Andrea Kundgen,
M. Lübbert,
R. Kunzmann,
A. Giagounidis,
...
C. Aul,
L. Trümper,
O. Krieger,
R. Stauder,
T. Müller,
F. Wimazal,
P. Valent,
C. Fonatsch,
C. Steidl
|
9 |
2007 |
9
🐜
|
|
🦁
|
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.
28 auth.
J. Schanz,
H. Tüchler,
F. Solé,
M. Mallo,
E. Luño,
J. Cervera,
I. Granada,
B. Hildebrandt,
M. Slovak,
K. Ohyashiki,
C. Steidl,
C. Fonatsch,
M. Pfeilstöcker,
T. Nösslinger,
P. Valent,
...
A. Giagounidis,
C. Aul,
M. Lübbert,
R. Stauder,
O. Krieger,
G. Garcia-Manero,
S. Faderl,
S. Pierce,
M. L. Le Beau,
J. Bennett,
P. Greenberg,
U. Germing,
D. Haase
|
9 |
2012 |
9
🦁
|
|
🐜
|
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
80 auth.
E. Bernard,
Y. Nannya,
R. Hasserjian,
S. Devlin,
H. Tuechler,
J. Medina-Martinez,
T. Yoshizato,
Y. Shiozawa,
R. Saiki,
L. Malcovati,
M. Levine,
Juan E. Arango,
Yangyu Zhou,
F. Solé,
C. Cargo,
...
D. Haase,
M. Creignou,
U. Germing,
Yanming Zhang,
G. Gundem,
Araxe Sarian,
A. A. van de Loosdrecht,
M. Jädersten,
M. Tobiasson,
O. Kosmider,
M. Follo,
F. Thol,
R. Pinheiro,
V. Santini,
I. Kotsianidis,
J. Boultwood,
F. P. Santos,
J. Schanz,
S. Kasahara,
T. Ishikawa,
H. Tsurumi,
A. Takaori-Kondo,
T. Kiguchi,
C. Polprasert,
J. Bennett,
V. Klimek,
M. Savona,
M. Belickova,
C. Ganster,
L. Palomo,
G. Sanz,
L. Adès,
M. D. Della Porta,
Harold Elias,
Alexandra G. Smith,
Yesenia Werner,
Minal A. Patel,
A. Viale,
K. Vanness,
D. Neuberg,
K. Stevenson,
K. Menghrajani,
K. Bolton,
P. Fenaux,
A. Pellagatti,
U. Platzbecker,
M. Heuser,
P. Valent,
S. Chiba,
Y. Miyazaki,
C. Finelli,
M. Voso,
L. Shih,
M. Fontenay,
J. Jansen,
J. Cervera,
Y. Atsuta,
N. Gattermann,
B. Ebert,
R. Bejar,
P. Greenberg,
M. Cazzola,
E. Hellström-Lindberg,
S. Ogawa,
E. Papaemmanuil
|
8 |
2019 |
8
🐜
|
|
🐜
|
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
29 auth.
P. Valent,
A. Orazi,
D. Steensma,
B. Ebert,
D. Haase,
L. Malcovati,
A. A. van de Loosdrecht,
T. Haferlach,
T. Westers,
D. Wells,
A. Giagounidis,
M. Loken,
A. Órfão,
M. Lübbert,
A. Ganser,
...
W. Hofmann,
K. Ogata,
J. Schanz,
M. Béné,
G. Hoermann,
W. Sperr,
K. Sotlar,
P. Bettelheim,
R. Stauder,
M. Pfeilstöcker,
H. Horny,
U. Germing,
P. Greenberg,
J. Bennett
|
7 |
2017 |
7
🐜
|
|
🐜
|
Time-dependent changes in mortality and transformation risk in MDS.
34 auth.
M. Pfeilstöcker,
H. Tuechler,
G. Sanz,
J. Schanz,
G. Garcia-Manero,
F. Solé,
J. Bennett,
D. Bowen,
P. Fenaux,
F. Dreyfus,
H. Kantarjian,
A. Kuendgen,
L. Malcovati,
M. Cazzola,
J. Čermák,
...
C. Fonatsch,
M. L. Le Beau,
M. Slovak,
A. Levis,
M. Luebbert,
J. Maciejewski,
S. Machherndl-Spandl,
S. Magalhães,
Y. Miyazaki,
M. Sekeres,
W. Sperr,
R. Stauder,
S. Tauro,
P. Valent,
T. Vallespí,
A. A. van de Loosdrecht,
U. Germing,
D. Haase,
P. Greenberg
|
7 |
2016 |
7
🐜
|
|
🦁
|
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system.
18 auth.
J. Schanz,
C. Steidl,
C. Fonatsch,
M. Pfeilstöcker,
T. Nösslinger,
H. Tuechler,
P. Valent,
B. Hildebrandt,
A. Giagounidis,
C. Aul,
...
M. Lübbert,
R. Stauder,
O. Krieger,
G. Garcia-Manero,
H. Kantarjian,
U. Germing,
D. Haase,
E. Estey
|
7 |
2011 |
7
🦁
|
|
🐜
|
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
32 auth.
U. Germing,
Michael Lauseker,
B. Hildebrandt,
A. Symeonidis,
J. Čermák,
P. Fenaux,
C. Kelaidi,
M. Pfeilstöcker,
T. Nösslinger,
M. Sekeres,
J. Maciejewski,
D. Haase,
J. Schanz,
J. Seymour,
M. Kenealy,
...
R. Weide,
M. Lübbert,
U. Platzbecker,
P. Valent,
K. Götze,
R. Stauder,
S. Blum,
K. Kreuzer,
R. Schlenk,
A. Ganser,
W. Hofmann,
C. Aul,
O. Krieger,
A. Kündgen,
R. Haas,
J. Hasford,
Aristoteles A N Giagounidis
|
7 |
2012 |
7
🐜
|
|
🐜
|
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
36 auth.
M. Mallo,
J. Cervera,
J. Schanz,
E. Such,
G. Garcia-Manero,
E. Luño,
Christian Steidl,
B. Espinet,
T. Vallespí,
U. Germing,
S. Blum,
Kazuma Ohyashiki,
J. Grau,
M. Pfeilstöcker,
J. Hernández,
...
T. Noesslinger,
A. Giagounidis,
C. Aul,
M. Calasanz,
María-Luisa Martín,
Peter Valent,
R. Collado,
C. Haferlach,
C. Fonatsch,
M. Lübbert,
Reinhard Stauder,
B. Hildebrandt,
O. Krieger,
C. Pedro,
L. Arenillas,
M. Sanz,
A. Valencia,
L. Florensa,
G. Sanz,
D. Haase,
F. Solé
|
6 |
2011 |
6
🐜
|
|
🐜
|
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)
35 auth.
M. D. Porta,
H. Tuechler,
L. Malcovati,
J. Schanz,
G. Sanz,
G. Garcia-Manero,
F. Solé,
John M. Bennett,
D. Bowen,
P. Fenaux,
F. Dreyfus,
H. Kantarjian,
A. Kuendgen,
A. Levis,
J. Čermák,
...
C. Fonatsch,
M. L. Beau,
M. Slovak,
O. Krieger,
Michael Luebbert,
J. Maciejewski,
S. Magalhães,
Y. Miyazaki,
M. Pfeilstöcker,
M. Sekeres,
W. Sperr,
R. Stauder,
S. Tauro,
P. Valent,
T. Vallespí,
A. A. Loosdrecht,
U. Germing,
D. Haase,
P. Greenberg,
M. Cazzola
|
6 |
2015 |
6
🐜
|
|
🐜
|
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
30 auth.
P. Valent,
A. Orazi,
M. Savona,
M. Patnaik,
F. Onida,
A. A. van de Loosdrecht,
D. Haase,
T. Haferlach,
C. Elena,
L. Pleyer,
W. Kern,
T. Pemovska,
G. Vladimer,
J. Schanz,
Alexandra Keller,
...
M. Lübbert,
T. Lion,
K. Sotlar,
A. Reiter,
T. D. de Witte,
M. Pfeilstöcker,
K. Geissler,
E. Padron,
Michael Deininger,
A. Órfão,
H. Horny,
P. Greenberg,
D. Arber,
L. Malcovati,
J. Bennett
|
6 |
2019 |
6
🐜
|
|
🐜
|
Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia
13 auth.
C. Müller-Thomas,
M. Rudelius,
Ina‐Christine Rondak,
T. Haferlach,
J. Schanz,
C. Huberle,
B. Schmidt,
R. Blaser,
M. Kremer,
C. Peschel,
...
U. Germing,
U. Platzbecker,
K. Götze
|
6 |
2014 |
6
🐜
|
